Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 297 of 1,261

  1. US 11186566

    Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

    Vertex Pharmaceuticals Incorporated · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  2. US 11185674

    Targeted delivery of biologic therapeutic agents

    Northwestern University · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  3. US 11185581

    Human rotavirus G9P[6] strain and use as a vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  4. US 11185572

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  5. US 11185564

    Compositions and methods for the treatment of wounds, disorders, and diseases of the skin

    Krystal Biotech, Inc. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  6. US 11186647

    Chimeric antigen receptors targeting BCMA and methods of use thereof

    LEGEND BIOTECH USA INC. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  7. US 11186646

    Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

    Five Prime Therapeutics, Inc. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  8. US 11186626

    Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop

    INTEGRATED BIOTHERAPEUTICS, INC. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  9. US 11186622

    PAC1 receptor agonists (MAXCAPS) and uses thereof

    The United States Government represented by the Department of Veterans Affairs · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  10. US 11186842

    Complement component iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  11. US 11186611

    Peptide with anti-obesity and anti-diabetes activity and use thereof

    CAREGEN CO., LTD. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  12. US 11186602

    Glucopyranosyl derivative and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  13. US 11186590

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  14. US 11186577

    Vasopressin receptor antagonists and products and methods related thereto

    BLACKTHORN THERAPEUTICS, INC. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  15. US 11186593

    Heterocycle amines and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  16. US 11186565

    Aromatic compound

    Takeda Pharmaceutical Company Limited · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  17. US 11185600

    Contrast agent and its use for imaging

    Stichting Radboud universitair medisch centrum · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  18. US 11186567

    AMPA receptor potentiators

    University College Cardiff Consultants Limited · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  19. US 11186533

    Chalcone compound and preparation method thereof

    SOUTH CHINA BOTANICAL GARDEN, CHINESE ACADEMY OF SCIENCES · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  20. US 11185575

    Subcutaneous administration of ADAMTS13

    Takeda Pharmaceutical Company Limited · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  21. US 11185585

    Methods and compositions for improving antiangiogenic therapy with anti-integrins

    The Regents of the University of California · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  22. US 11185592

    Spirocyclic degronimers for target protein degradation

    C4 THERAPEUTICS, INC. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  23. US 11185580

    Compositions, methods and uses for improved human papilloma virus constructs

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  24. US 11185577

    H3.3 CTL peptides and uses thereof

    The Regents of the University of California · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.